Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
Status:
Completed
Trial end date:
2017-07-20
Target enrollment:
Participant gender:
Summary
The purpose of this study was to investigate the efficacy, safety, and pharmacokinetics of
adalimumab in Japanese participants with generalized pustular psoriasis (GPP) who did not
have an adequate response to their currently approved treatment.